(Q34648667)

3 August 2017

0 references

1 reference

title

Valganciclovir: an advance in cytomegalovirus therapeutics (English)

1 reference

3 August 2017

0 references

1 reference

Jennifer M Cocohoba

1

1 reference

PubMed ID

12022911

3 August 2017

Ian R McNicholl

series ordinal

2

1 reference

PubMed ID

12022911

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Annals of Pharmacotherapy

3 August 2017

1 reference

3 August 2017

36

1 reference

3 August 2017

1075-1079

1 reference

3 August 2017

6

1 reference

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

3 August 2017

1 reference

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

21 January 2018

1 reference

Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

21 January 2018

1 reference

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

21 January 2018

1 reference

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

21 January 2018

1 reference

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A393

1 reference

3 August 2017

1 reference

PubMed ID

12022911